← Back to all trials
Recruiting
NCT05640037
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
Conditions: Sepsis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Enrollment: 120
Sponsor: Zhongnan Hospital
Location: China
Summary
This study aims to evaluate the efficacy of IL-37 as a biomarker to predict mortality risk in adults with sepsis.
Eligibility Criteria
Inclusion Criteria:Age 18 years or olderExpected length of stay>24 hours in intensive care unit (ICU)Sequential organ failure assessment (SOFA) score ≥ 2 on ICU admission with a suspicion of infectionExclusion Criteria:anuriaICU readmission in 28 days
Source: ClinicalTrials.gov (NCT05640037). StuddyBuddy aggregates publicly available trial information.
